DMPI Faculty member, Bill Kraus
Over 200 million people worldwide take statins to help lower their cholesterol, which helps reduce the risk of illness and mortality for those in danger of contracting heart disease.
James B. Wyngaarden Distinguished Professor of Medicine and DMPI Associate Director David D’Alessio, MD is one of 24 awarded Duke Distinguished Professorships. Dr. D'Alessio is a professor of medicine and chief of the Division of Endocrinology and Metabolism.
The research article A metabolomics comparison of plant-based meat and grass-fed meat indicates large nutritional differences despite comparable Nutrition Facts panels is one of the top 100 downloaded papers for Scientific Reports in 2021. This research was featured in a News article on the DMPI website.
DMPI faculty member Rasheed Gbadegesin, MD, MBBS is one of two in the Duke University School of Medicine elected to the Association of American Physicians (AAP). They were inducted during the joint meeting of the AAP, the American Society for Clinical Investigation (ASCI), and the American Physician-Scientists Association (APSA) on April 8, 2022.
We are extremely pleased to announce that Dr. Rana Gupta has agreed to join the DMPI faculty, with an anticipated start date in the summer, 2022.
The DMPI Metabolomics Lab has been awarded a large NIH Common Fund grant to become part of the Metabolomics and Clinical Assay Core (MCAC) for the new NIH Common Fund-Sponsored Precision Nutrition Initiative. The DMPI will receive $3.2M over four years, primarily to fund targeted metabolomics and clinical analyte measurements, with possibilities to branch out to non-targeted and metabolic flux studies as the project evolves.
A recent paper by Rasheed Gbadegin’s team in JCI Insight found that a rare variant in CLVS1 is a likely cause of hereditary steroid sensitive nephrotic syndrome (SSNS). This study was partly funded by BORDEN Scholars program which was awarded to Dr. Gbadegesin in 2020.